Tm Bioscience Announces Board Change
News Feb 02, 2006
Tm Bioscience Corporation has announced that Dr. Trevor L. Hawkins has resigned from the Company's Board of Directors, effective immediately.
"By sharing his deep understanding of the molecular diagnostics industry with us, Dr. Hawkins has significantly enhanced this company," said Greg Hines, President and CEO of Tm Biosciences.
"Unfortunately, a change in employment and relocation to Europe has made it necessary for him to resign from our Board."
"On behalf of the Board of Directors and management team at Tm Bioscience, we thank Trevor and wish him the very best in his future endeavors."
CRISPR Screening Reveals Sickle Cell Disease TargetNews
A key signaling protein, known as heme-regulated inhibitor (HRI), has been identified as a potential therapeutic target for the development of drugs to treat sickle cell disease, using a CRISPR screening approach.READ MORE
DNA Methylation Related to Liver Disease in Obese PatientsNews
DNA methylation implicated in initiation of liver fibrosis in non-alcoholic fatty liver diseaseREAD MORE
UCL Technology Fund Investment MeiraGTx Raises $75 Million in IPONews
MeiraGTx Holdings plc raised $75 million of gross proceeds upon close of the company’s initial public offering (IPO).READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018